| Literature DB >> 28577786 |
John Chao1, Andrew Pao2.
Abstract
Symptomatic osteochondral lesions of the talus remain a challenging problem due to inability for cartilage lesions to heal. Numerous treatment options exist, including nonoperative management, marrow stimulating techniques, and autograft-allograft. Arthroscopic marrow stimulation forms fibrocartilage that has been shown to be biomechanically weaker than hyaline cartilage. Restorative tissue transplantation options are being used more for larger and cystic lesions. Newer biologics and particulated juvenile cartilage are currently under investigation for possible clinical efficacy. This article provides an evidenced-based summary of available literature on the use of biologics for treatment of osteochondral lesions of the talus.Entities:
Keywords: DeNovo; Osteochondral allograft; Osteochondral autologous transplant; Osteochondral lesion of talus; PRP
Mesh:
Year: 2017 PMID: 28577786 DOI: 10.1016/j.ocl.2017.03.008
Source DB: PubMed Journal: Orthop Clin North Am ISSN: 0030-5898 Impact factor: 2.472